spacer
home > news > detailed info
INDUSTRY NEWS AND PRESS RELEASES

Micro dosing pumps in global use against COVID-19

HNP Mikrosysteme

From diagnostics and research to future vaccine production, micropumps can be used in the fight against COVID-19

(PresseBox) ( Schwerin, 24.06.20 ) Automated analysis devices are the essential basis for extensive test capacities for the corona virus. Through parallel and faster processes, automation significantly increases the number of tests, saves manpower and ensures process reliability. For sample preparation for SARS-CoV-2, a few microliters of a solution of chemicals and enzymes are dosed. Micro annular gear pumps of the low pressure series from HNP Mikrosysteme perform this demanding task with highest precision and process reliability. The minimum dosing quantity is 0.25 µl, the pumps have a very small footprint and can be easily integrated into control systems. Fully automated analysis devices can contain up to sixteen dosing pumps and can handle up to 4,000 samples in 24 hours.

Micro dosing pumps are also used in research on vaccines and therapies against COVID-19. Every development step in research institutes at universities, in international pharmaceutical companies or in start-ups worldwide is accompanied by numerous laboratory tests. This is a mammoth task, which is also carried out automatically.

Micro pumps of various series, such as hermetically inert pumps, are used in the production of vaccines. From diagnostics and research to future vaccine production, micropumps can be used in the fight against COVID-19. In applications requiring small and very small quantities of liquids delivered with high precision, mzr-pumps by HNP Mikrosysteme provide accurate service and ensure process reliability.

HNP Mikrosysteme GmbH
HNP Mikrosysteme GmbH, located in Germany, develops, manufactures and markets pumps and systems worldwide which deliver small amounts of liquids fast and accurately. Beside several applications in plant engineering, chemical processing and pharmaceutical processing, mzr-pumps are used in the field of life science and analytical instrumentation.
phone +49 385 52190-300
email info@hnp-mikrosysteme.de
web https://www.hnp-mikrosysteme.de/en/
email Bleicherufer 25 19053 Schwerin
 
Print this page
Send to a friend
   
spacer
News and Press Releases

Max Planck researchers feed Proteome AI with PharmaFluidics technology

PharmaFluidics NV, innovative player in the field of analytical chromatography, is excited to announce that researchers of Prof. Matthias Mann’s Group at the Max Planck Institute in Munich have integrated its unique high-resolution µPAC™ micro-Chip technology in their advanced proteomics workflow.
More info >>


White Papers

Antibody Internalization: Advanced Flow Cytometry and Live-Cell Analysis Give Rich Insights During Antibody Profiling

Sartorius Group

The natural characteristics of antibodies, such as high binding affinity, specificity to a wide variety of targets, and good stability, make them ideal therapeutic candidates for many diseases. Monoclonal antibodies (mAbs), in particular, deliver promising therapeutic results in several different disease areas, such as autoimmunity, oncology, and chronic inflammation. Researchers’ abilities to improve the breadth of antibodies have been aided by innovative technologies for antibody discovery, for instance, through humanization of mouse antibodies and phage display. However, advanced antibody design techniques create the need for new screening methods so that lead candidates can be quickly and effectively identified as early in the development process as possible.
More info >>

Industry Events

Outsourcing in Clinical Trials Europe

26-27 October 2020, Paris, France

Arena International are delighted to announce the return of Outsourcing in Clinical Trials Europe. Part of our global series of events, this flagship show will attract the leading clinical professionals from across Europe. The 10th Annual event will be hosted in Paris.
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement